Thrombocytopenia predicts thrombosis risk, poor survival in antiphospholipid syndrome
Clinical Characteristics and Prognosis of Antiphospholipid Syndrome Patients Based on Cluster Analysis: A 10-year Cohort Study - ISTH Congress Abstracts
Antiphospholipid Syndrome – Synapse
Antiphospholipid (APL / APS) / Hughes syndrome | Facebook
Frontiers | Environmental Triggers of Autoreactive Responses: Induction of Antiphospholipid Antibody Formation
Antiphospholipid syndrome breakthrough: Cell-surface targets identified, opening path to therapies
The antiphospholipid syndrome – often overlooked cause of vascular occlusions? - Svenungsson - 2020 - Journal of Internal Medicine - Wiley Online Library
Antiphospholipid Syndrome: Role of Vascular Endothelial Cells and Implications for Risk Stratification and Targeted Therapeutics - ScienceDirect
Pathogenic mechanisms of thrombosis in APS. aPL disrupt the coagulation... | Download Scientific Diagram
Apl de aps hi-res stock photography and images - Alamy
Pregnancy Management in Patients with SLE and/or APS ... | GrepMed
Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome | SpringerLink
Treatment in thrombotic antiphospholipid syndrome: a review - T S Vadgama, A Smith, M L Bertolaccini, 2019
JCM | Free Full-Text | Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review
Characterization of Antiphospholipid Syndrome Atherothrombotic Risk by Unsupervised Integrated Transcriptomic Analyses | Arteriosclerosis, Thrombosis, and Vascular Biology
Introductory Chapter: Antiphospholipid Antibodies - A Laboratory Criterion for the Antiphospholipid Syndrome, but Also Bystanders in Infections, Cancer, and Other Conditions | IntechOpen
AB0487 Antiphospholipid Syndrome and Epilepsy: Where Do We Stand? | Annals of the Rheumatic Diseases
